Market Data
iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund. The fund holds $3.7B in assets.
Distributions
iShares U.S. Medical Devices ETF paid $0.262 per share over the last 12 months, a trailing 12-month distribution yield of 0.45% at the current price. It pays quarterly.
| Ex-date | Amount | Type |
|---|---|---|
| Sep 15, 2026 | $0.081 | Regular |
| Jun 15, 2026 | $0.075 | Regular |
| Mar 17, 2026 | $0.043 | Regular |
| Dec 16, 2025 | $0.063 | Regular |
| Sep 16, 2025 | $0.061 | Regular |
| Jun 16, 2025 | $0.055 | Regular |
| Mar 18, 2025 | $0.033 | Regular |
| Dec 17, 2024 | $0.107 | Regular |
Yield counts regular payments only and is computed from paid distributions and the latest close; it is not the SEC 30-day yield. The next ex-date is estimated from the payment schedule.
Behaviour On Record
iShares U.S. Medical Devices ETF is currently running 28.5% annualised volatility over the last 21 sessions. Measured against IHI's own 13 years of daily returns rather than a market-wide average, that is the 92nd percentile — an extreme by its own standards, against a typical reading of 16.2%.
IHI is trading -10.5% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -14.3%, and the deepest was -33.3% in 2020. The current pullback is therefore shallower than what this fund gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +12.9% from its 200-day moving average. Against every other day in its history, that gap ranks at the 91st percentile — a wider gap than this fund usually carries. Over the past year IHI closed higher on 48% of sessions, and it is currently 2 sessions into a rising streak.
On November specifically: over 13 years of records, IHI finished the month higher 11 of 13 times, with a median return of +3.6% and an average of +3.2%. Its strongest month historically has been November at +3.2% on average, its weakest September at -2.2%.
Overnight risk is measurable too: IHI has opened more than 2% away from the prior close in 66 of 3,268 sessions (2.0% of the time), with the largest gaps running +5.6% and -7.6%.
All figures computed from 3,269 daily closes between 2013-11-06 and 2026-11-05, split-adjusted, recomputed daily. Percentiles are against IHI's own 13-year history, not a peer group or index.
Industry Rotation
IHI tracks Medical Devices, which ranks 1 of 15 industry ETFs on DailyIQ's rotation score (100/100) and is classed as Leading. Over the last three months it has outperformed the S&P 500 (SPY) by 13.2 points.
| Period | IHI | vs SPY |
|---|---|---|
| 1 week | +6.2% | +8.9% |
| 1 month | +15.9% | +20.8% |
| 3 months | +8.6% | +13.2% |
| Year to date | -5.0% | -12.9% |
| 1 year | -3.3% | -12.8% |
Rotation score is a percentile within the industry group, built from relative strength against SPY over 1 week, 1 month and 3 months, its acceleration, rank change, volume and position against the 20- and 50-day averages, as of the Nov 6, 2026 close. See all sectors.
News & sentiment
IHI rose 14.4% over the month to Nov 5. Daily news tone ranged from 32 to 58 and read 46 on Nov 3.
Technical analysis
On the daily chart IHI ranks at the 23rd percentile for momentum against 1,061 stocks and ETFs, a bearish reading.
Institutional ownership
29 of the 55 tracked managers added to IHI in their latest 13F and 22 trimmed. Together their positions are worth $1.0B.
Discover more
Over the six months to Nov 5, IHI returned +18.6%. Of the 15 related stocks and ETFs, 7 did better, led by BDX at +48.1%.
